Condition (MeSH)
Bladder Exstrophy
ClinicalTrials.gov lists 16 trials for Bladder Exstrophy or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Bladder Exstrophy itself; the rest are tagged with a narrower condition beneath it.
When did Bladder Exstrophy trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 4 |
| 2018 | 1 |
| 2017 | 2 |
| 2015 | 1 |
| 2013 | 1 |
| 2012 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Bladder Exstrophy trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Not applicable | 6 |
| Observational | 7 |
How many Bladder Exstrophy trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 6 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Bladder Exstrophy? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Platelet Rich Fibrin | 1 |
| MDC | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| ACT | 1 |
| Ropivacaine (Epidural analgesia) continuous infusion | 1 |
| Chloroprocaine intermittent bolus | 1 |
| Neonatal Cystourethroscope Injection | 1 |
| Myoblast transplantation | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Bladder Exstrophy? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Radial forearm free flap phalloplasty for penile inadequacy in patients with exstrophy. | The Journal of urology | 2013 | Yes |
| Register based study of bladder exstrophy-epispadias complex: prevalence, associated anomalies, prenatal diagnosis and survival. | The Journal of urology | 2011 | Yes |
| Failed exstrophy closure: management and outcome. | Journal of pediatric urology | 2010 | Yes |
| Transurethral autologous myoblast injection for treatment of urinary incontinence in children with classic bladder exstrophy. | The Journal of urology | 2008 | Yes |
| Determinants of continence in the bladder exstrophy population: predictors of success? | Urology | 2001 | Yes |
Showing 5 of 7 publications.
Prevalence (15)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Classic bladder exstrophy | Prevalence at birth | 1-9 / 100 000 | United States | US | Unspecified |
| Classic bladder exstrophy | Prevalence at birth | 1-9 / 100 000 | United States | US | Exact |
| Classic bladder exstrophy | Prevalence at birth | 1-9 / 100 000 | United States | US | Exact |
| Classic bladder exstrophy | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Unspecified |
| Classic bladder exstrophy | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Exact |
Showing 5 of 15 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Classic bladder exstrophy | 93930 | Exact | Orphadata Science knowledge files, Product 1 |
| Classic bladder exstrophy | 93930 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors and serious adverse events in this condition's trials.